1-4 of 4
Chaz Moreno
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mosunetuzumab Plus Polatuzumab Vedotin Induces Early Complete Responses in Previously Untreated High Tumor Burden Follicular Lymphoma

David A Russler-Germain, Fei Wan, Emily R. King, Chaz Moreno, Michelle Becker-Hapak, Patrick Pence, Joseph Rueve, Sushanth A Pureti, Dilan A. Patel, Brad S. Kahl, Neha Mehta-Shah, Todd A Fehniger, Nancy L. Bartlett
Journal: Blood
Blood (2024) 144 (Supplement 1): 4414.
https://doi.org/10.1182/blood-2024-202085
Published: 2024
Journal Articles

Phase I Results of Acalabrutinib in Combination with Durvalumab in Primary Central Nervous System Lymphoma: Safety, Efficacy, and Central Nervous System Penetration

Imran A. Nizamuddin, Narendranath Epperla, Mary-Kate Malacek, Brad S. Kahl, Fei Wan, Anne Fischer, Chaz Moreno, Emily R. King, Anna Krivenko, Nancy L. Bartlett, Neha Mehta-Shah
Journal: Blood
Blood (2024) 144 (Supplement 1): 985.
https://doi.org/10.1182/blood-2024-204521
Published: 2024
Journal Articles

Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive Lymphomas

Neha Mehta-Shah, MD, Peter A. Riedell, MD, Nancy L. Bartlett, MD, Amanda F Cashen, MD, Brad S. Kahl, MD, Todd A Fehniger, MD PhD, Chaz Moreno, Jingxia Liu, MS, PhD, Kenneth R. Carson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1550.
https://doi.org/10.1182/blood-2019-124185
Published: 2019
Journal Articles

Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive Lymphomas Including AITL and DLBCL: Phase I Results

Neha Mehta-Shah, MD, Peter A Riedell, MD, Nancy L. Bartlett, MD, Amanda F Cashen, MD, Brad S Kahl, MD, Todd A Fehniger, MD PhD, Chaz Moreno, Kenneth R. Carson, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2929.
https://doi.org/10.1182/blood-2018-99-113611
Published: 2018